home / stock / prtc / prtc news

PRTC News and Press, PureTech Health plc From 02/10/21

Stock Information
Company Name: PureTech Health plc
Stock Symbol: PRTC
Market: NASDAQ
Website: puretechhealth.com
Menu
PRTC PRTC Quote PRTC Short PRTC News PRTC Articles PRTC Message Board
Get PRTC Alerts

News, Short Squeeze, Breakout and More Instantly...
PRTC - PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares

PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announced that it has sold...
PRTC - Vedanta Biosciences Appoints Mark Mullikin as Chief Financial Officer

Extensive biotech finance and investor relations expertise includes leadership roles at Editas Medicine and Novartis Vedanta Biosciences , a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined con...

PRTC - PureTech Founded Entity Vedanta Biosciences Appoints Mark Mullikin as Chief Financial Officer

Extensive biotech finance and investor relations expertise includes leadership roles at Editas Medicine and Novartis PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicate...

PRTC - PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering

PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note tha...
PRTC - PureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33

Phase 1/2a clinical trial expected to begin in first half of 2021 PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”) is pleased to note that its Founded Entity, Vor Biopharma , a clinical-stage cell therapy company...

PRTC - PureTech Founded Entity Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to its Board of Directors

Bringing a depth of expertise in product registration, commercial & business development Tom Wiggans, former CEO of Dermira, joins as Executive Chairman Michael Davin, former CEO of Cynosure, joins Board of Directors PureTech Health plc (LSE: PRTC, NA...

PRTC - Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to Its Board of Directors

Bringing a depth of expertise in product registration, commercial & business development Tom Wiggans, former CEO of Dermira, joins as Executive Chairman Michael Davin, former CEO of Cynosure, joins Board of Directors Follica Inc. (“Follica”...
PRTC - PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

Michael Vincent, M.D., Ph.D., Chief Scientific Officer, Inflammation & Immunology Research Unit at Pfizer, to join Vedanta’s Scientific Advisory Board PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company&#x...

PRTC - Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

Michael Vincent, M.D., Ph.D., Chief Scientific Officer, Inflammation & Immunology Research Unit at Pfizer, to join Vedanta’s Scientific Advisory Board Vedanta Biosciences , a leading clinical-stage company developing a new category of therapies for...

PRTC - PureTech Announces the Appointment of George Farmer, Ph.D., as Chief Financial Officer

Experienced financial analyst and biotech executive added to PureTech’s strong leadership team PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discoverin...
Previous 10 Next 10